background media novel monoclonal antibody mab neutral group ii influenza virus ia vitro value whether effect prophylaxi therapy metres hn tandem mouse ferret could use block transmits npd compare irrelev control r oseltamivir method admins intraperiton inject vari dose hour prior entrants infect postinfect treatment comparison along combine include studi survive weight loss viral tier ass day studi period nav respiratory contact receive exposure infect virus result clear dosedepend response superior lethal pl better early equal yield similar protect delay abl protect airborne concur show promise potent admit block unique find among influenzaspecif mab 